Advanced Oncotherapy PLC

Receive alerts
Market Cap:
£91.66 m
37.50 GBX
52 weeks high
52 weeks low

In brief

Advanced Oncotherapy is a specialist developer and provider of a breakthrough proton therapy system, the LIGHT system, which is the result of 25 years of work at CERN and ADAM.

Our focus is on developing and supplying technologies to maximise the destructive effect of radiation on tumours whilst minimising damage to the patient's healthy tissues.

Advanced Oncotherapy plc operates from three main locations:

  • the head office in London, UK
  • the R&D facility ADAM S.A. (Applications of Detectors and Accelerators to Medicine), in Geneva, Switzerland
  • the US operations in Syracuse, NY

Deep dive We explore the investor case for growth companies


Work at Advanced Onco’s Harley Street facility is due to complete within the next few months, and the first patient treated by LIGHT is slated for the second half of 2020

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Proton beam therapy will become as common as MRI scanning believes Advanced Oncotherapy's chief executive

Nicholas Serandour explains the science and potential of Advanced Oncotherapy's pioneering proton therapy cancer treatment

on 9/8/19